Sale!

ARID1A Gene Mental Retardation Autosomal Dominant Type 14 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ARID1A Gene Mental Retardation Autosomal Dominant Type 14 Genetic Test is a specialized diagnostic tool designed to identify mutations in the ARID1A gene, which are linked to a form of mental retardation characterized as Autosomal Dominant Type 14. This condition is part of a broader spectrum of intellectual disabilities that can vary in severity and is inherited in an autosomal dominant manner, meaning only one copy of the altered gene in each cell is sufficient to cause the disorder.

Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, this test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to detect any mutations in the ARID1A gene that could be responsible for the condition.

The cost of the ARID1A Gene Mental Retardation Autosomal Dominant Type 14 Genetic Test is 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated equipment and expertise required to accurately identify gene mutations and interpret the results.

This test is crucial for families seeking answers about intellectual disabilities and offers insights that can guide decisions about care and support. It also has implications for genetic counseling, helping families understand the risk of passing the condition to future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ARID1A Gene Mental Retardation Autosomal Dominant Type 14 Genetic Test

At DNA Labs UAE, we offer the ARID1A Gene Mental Retardation Autosomal Dominant Type 14 Genetic Test. This test is designed to diagnose and provide information about mental retardation, autosomal dominant type 14 (MRD14), a condition characterized by intellectual disability, developmental delay, and other neurological features.

Test Components

  • Price: 4400.0 AED

Sample Condition

We accept blood samples, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

Reports are typically delivered within 3 to 4 weeks.

Method

We use NGS technology for this genetic test. NGS, or next-generation sequencing, allows for the simultaneous analysis of multiple genes and provides quick and accurate sequencing of an individual’s DNA.

Test Type

This test is specifically designed for neurological disorders.

Doctor

This test is conducted by our experienced neurologists.

Test Department

This test falls under our Genetics department.

Pre Test Information

Prior to the test, we recommend providing the clinical history of the patient who is undergoing the ARID1A Gene Mental Retardation Autosomal Dominant Type 14 NGS Genetic DNA Test. We also offer a genetic counseling session to draw a pedigree chart of family members affected by MRD14.

Test Details

The ARID1A gene is associated with mental retardation, autosomal dominant type 14 (MRD14). This condition is characterized by intellectual disability, developmental delay, and other neurological features. Our NGS genetic testing allows for the identification of mutations or variants in the ARID1A gene that may be responsible for the condition. This testing can confirm a diagnosis, provide information about the genetic cause of the condition, and guide genetic counseling and management options for individuals and their families.

It is important to note that the ARID1A gene is also associated with various types of cancer. Therefore, the specific indication for ARID1A gene testing may vary depending on the clinical context and suspected diagnosis.

Test Name ARID1A Gene Mental retardation autosomal dominant type 14 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ARID1A Gene Mental retardation, autosomal dominant type 14 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ARID1A Gene Mental retardation, autosomal dominant type 14
Test Details

The ARID1A gene is associated with a condition called mental retardation, autosomal dominant type 14 (MRD14). This condition is characterized by intellectual disability, developmental delay, and other neurological features.

NGS genetic testing, or next-generation sequencing genetic testing, is a type of genetic testing that allows for the simultaneous analysis of multiple genes. It uses advanced sequencing technology to quickly and accurately sequence an individual’s DNA.

In the context of MRD14, NGS genetic testing can be used to identify mutations or variants in the ARID1A gene that may be responsible for the condition. This testing can help confirm a diagnosis, provide information about the genetic cause of the condition, and inform genetic counseling and management options for individuals and their families.

It’s important to note that the ARID1A gene is associated with other conditions as well, including various types of cancer. Therefore, the specific indication for ARID1A gene testing may vary depending on the clinical context and suspected diagnosis.